CWMI Joins Metro Bacolod Hospital’s Medical Mission to Promote Accessible Healthcare
- Admin

- Oct 21
- 2 min read
Bacolod City, Philippines – October 21, 2025 – Central West Medicale Inc. (CWMI) proudly participated in the Medical Mission organized by Metro Bacolod Hospital and Medical Center on October 20, 2025, reinforcing the company’s commitment to making healthcare more accessible and advancing community wellness across the region.

The CWMI delegation was led by Ms. Regine Treyes, District Sales Manager – Western Visayas, alongside Medical Sales Representatives Ms. Gina Tuazon and Mr. Joelito Gabatero. The team actively engaged with participants and healthcare volunteers, highlighting CWMI’s dedication to fostering partnerships that drive positive health outcomes in local communities.

As part of the initiative, Central West Medicale Inc. set up an informative product booth featuring its flagship consumer healthcare brands — Centracid, a trusted antacid providing fast and lasting relief from hyperacidity, and Zentokid, a zinc supplement formulated to strengthen children’s immunity and support healthy growth. CWMI representatives also conducted health education sessions and product awareness activities, helping attendees better understand preventive care and wellness management.

“Participating in this medical mission is part of our broader mission to serve communities and bring quality healthcare solutions closer to every Filipino,” said Ms. Treyes. “We are grateful to Metro Bacolod Hospital and Medical Center for this opportunity to collaborate in promoting health awareness and improving access to care.”

Central West Medicale Inc. extends its sincere appreciation to the event organizers, partner institutions, and healthcare professionals who worked tirelessly to make the mission a success.

Through continued partnerships and outreach efforts, CWMI remains steadfast in its vision of building stronger, healthier communities — one initiative at a time — as part of its advocacy Towards a Healthier Philippines.








Comments